News Breaks |
|
|
| April 9, 2010 |
| 07:07 EDT |  | BSX, BAC, ABT, JNJ | Boston Scientific hires Bank of America to sell two units, Bloomberg reports
Boston Scientific (BSX) has reportedly hired Bank of America (BAC) to advise it on the sale of its Target Therapeutics and neuromodulation units, Bloomberg reports, citing a person with knowledge of the matter. Potential buyers have been approached in recent weeks, the source says. Wells Fargo analyst Larry Biegelsen says the two units could bring in about $2B in a sale. Bernstein analyst Derrick Sung says Johnson & Johnson (JNJ) could buy the neuromodulation unit and Abbott (ABT) may have interest in the Target unit. Reference Link |
|
|
News For BSX;BAC;ABT;JNJ From The Last 14 Days Check below for free stories on BSX;BAC;ABT;JNJ the last two weeks. |
|
|
| May 17, 2013 |
| 16:00 EDT |  | BAC | Options Update; May 17, 2013
 Subscribe for More Information |
|
| 10:20 EDT |  | BAC | Bank of America rises, levels to watch
Subscribe for More Information |
|
| 06:19 EDT | | JNJ | J&J to end sales of of metal-on-metal hip replacements, Bloomberg reports
Subscribe for More Information |
|
| May 16, 2013 |
| 16:13 EDT |  | BSX | Vascular Solutions files patent infringement complaint against Boston Scientific
Vascular Solutions (VASC) announced that it has filed a patent infringement complaint in the U.S. District Court for the District of Minnesota against Boston Scientific Corporation (BSX). The complaint alleges that Boston Scientific has infringed three patents owned by Vascular Solutions concerning rapid exchange guide extension technology by manufacturing and selling its Guidezilla guide extension catheter which received 510(k) clearance in March. Vascular Solutions is seeking an injunction against Boston Scientific prohibiting the manufacture and sale of its Guidezilla catheter as well as damages for lost profits and legal costs. |
|
| 07:51 EDT |  | BSX | Boston Scientific price target raised to $12 from $9 at JMP Securities
JMP Securities increased its price target on Boston Scientific as the firm believes after speaking with experts that S-ICD devices can be used in 50% of de novo implant cases, up from its previous estimate of 30%. The firm's FY13 and FY14 earnings estimates for the company are well above consensus levels and it reiterates an Outperform rating on the shares. |
|
| 07:28 EDT |  | BSX | I/O Central to host a conference
Subscribe for More Information |
|
| 07:18 EDT | | BAC | Investors bet on banks hit by credit crisis, Bloomberg reports
Subscribe for More Information |
|
| 06:41 EDT | | BAC | Big banks to benefit from U.S. concession on derivatives, NY Times says
Subscribe for More Information |
|
| May 15, 2013 |
| 16:51 EDT | | JNJ | FDA approves Simponi to treat ulcerative colitis
Subscribe for More Information |
|
| 10:13 EDT | | BAC | Bank of America reports April card write-offs 4.55% vs. 4.33% last month
Subscribe for More Information |
| |
| May 14, 2013 |
| 15:33 EDT | | BSX | Boston Scientific has a conference call hosted by JPMorgan
JPMorgan Analyst Weinstein will host a conference call with CEO Mike Mahoney on May 17 at 11 am. |
|
| 10:53 EDT | | BAC | Bank of America breakout continues, levels to watch
The breakout back above what was persistent resistance at the $12.50 area has now taken on a firmer bullish footing. Shares are trading at multi-year highs, last at $13.25. At that price, resistance is now at $13.56 and then at $13.84. Support is at $13.01. |
|
| 08:44 EDT | | BAC | Bank of America management to meet with Deutsche Bank
Subscribe for More Information |
|
| 08:33 EDT | | BAC | CFTC investigates swap contracts, FT reports
The Commodity Futures Trading Commission issued a “special call” asking Wall Street banks and other traders to provide documents that would prove recent derivatives transactions known as “exchanges of futures for swaps” were legal. Lawyers at the CFTC enforcement division are also scrutinizing the trades for possible violations. The probe is into the legitimacy of more than 1M energy and metals transactions by the biggest traders in commodities markets over the past two years.Reference Link |
|
| 06:19 EDT | | BAC | Brokerage firms see market share drop, competition increase, Bloomberg reports
Subscribe for More Information |
|
| May 13, 2013 |
| 15:04 EDT | | BAC | Fed says large banks must submit midyear stress tests on July 5
Eighteen large U.S. bank holding companies are required to submit the results of their company-run, midyear stress tests to the Federal Reserve on July 5, the Federal Reserve said. The Dodd-Frank Wall Street Reform and Consumer Protection Act required that large bank holding companies and non-bank financial institutions that are designated for Federal Reserve supervision by the Financial Stability Oversight Council conduct two stress tests each year. In the midyear test, which is being conducted for the first time in 2013, each firm develops its own baseline, adverse, and severely adverse scenarios to best reflect its individual operations and risks. Each firm in the midyear test is required to release the results produced under its severely adverse scenario, helping promote market discipline and understanding of the financial conditions and risks of individual firms, between September 15 and September 30, the Fed added. |
|
| May 10, 2013 |
| 11:48 EDT | | JNJ | Drugmakers to face pressure on U.S. prices, Reuters says
Subscribe for More Information |
|
| 10:00 EDT |  | BSX | On The Fly: Analyst Upgrade Summary
Subscribe for More Information |
|
| 09:03 EDT | | BSX | Boston Scientific receives CEO Mark approval for Rhythmia mapping system
Subscribe for More Information |
|
| 07:33 EDT | | BAC | New York's case against BofA, Merrill may be dropped, Reuters reports
Subscribe for More Information |
| |
|
|
|
|
